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Fritsch and Bobbitt Named NAI Fellows 
  
 The National Academy of Inventors (NAI) has named 170 dis-
tinguished innovators to NAI Fellow status, increasing the total number 
of NAI Fellows to 414.  The NAI Fellows will be inducted on March 20, 
2015, as part of the 4th Annual Conference of the National Academy of 
Inventors at the California Institute of Technology in Pasadena, CA.  
U.S. Patent and Trademark Office (USPTO) Deputy Commissioner for 
Patent Operations Andrew Faile will be providing the keynote address 
for the induction ceremony.  Fellows will be presented with a special 
trophy, newly designed medal, and rosette pin in honor of their out-
standing accomplishments. 
 The department is proud of the fact that one of its own, Dr. 
Ingrid Fritsch, was named an NAI Fellow.  Says Fritsch, “I’m delighted 
to be named a fellow of the National Academy of Inventors.  This 
recognition validates my vision and efforts toward building up the sci-
ence and technology base in Arkansas in association with the area’s scientific and business communi-
ty with meaningful impact on the world.  Scientific advances do not take place in a vacuum.  They 
require a cooperative endeavor of inspiring people with diverse expertise.  I accept this recognition 
on behalf of the team of co-inventors, students, and collaborators with whom new ideas have blos-
somed and discoveries have been made.  I am also grateful to my university, region, and state, where 
research and entrepreneurship are encouraged and supported.”   
 Dr. Ingrid Fritsch is a Professor in the Department of Chemistry and Biochemistry at the 
University of Arkansas.  She received a B.S. degree from the University of Utah and a Ph.D. from the 
University of Illinois at Urbana-Champaign and was a postdoctoral associate at the Massachusetts 
Institute of Technology.  Fritsch has pioneered the field of redox-magnetohydrodynamic microfluid-
ics and developed multifunctional miniaturized analytical devices and sensors, including protein and 
DNA-hybridization microarrays interfaced to electrochemical detection. This work is important in 
developing portable devices for environmental and point-of-care chemical analysis.  She is the recipi-
ent of the 1997 Society of Electroanalytical Chemistry Young Investigator Award, a National Science 
Foundation Career Award, an NSF Special Creativity Extension, and an American Chemical Society 
Chemistry Ambassadorship.  She holds ten issued U.S. patents (nine licensed), co-founded two 
startup companies, and currently serves as a Member of the Board of Directors of SFC Fluidics, Inc. 
(Fayetteville, AR).  
 Formerly from the department, Dr. Donald R. Bobbitt was 
also named an NAI Fellow.  He was awarded patents for discoveries he 
made in the 1990s as a faculty member.  Dr. Bobbitt now serves as 
president of the University of Arkansas System.  Both Fritsch and Bob-
bitt were recognized by the academy with a full-page announcement in 
The Chronicle of Higher Education on January 16, and will appear in forth-
coming issues of Inventors Digest and Technology and Innovation - Proceed-
ings of the National Academy of Inventors.   
 According to the academy, election to NAI Fellow status is a 
high professional distinction accorded to academic inventors who have 
demonstrated a highly prolific spirit of innovation in creating or facili-
tating outstanding inventions that have made a tangible impact on quali-
ty of life, economic development, and the welfare of society. 
 
To see the full article on the University of Arkansas Newswire, please go to http://bit.ly/1Lhtl0k 
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Technology Company TiFiberTM to Establish Production Facility in Fort Smith 
 
     TiFiber was formed in 2010 to commercialize a patented titanium dioxide based nanofiber membrane technology exclu-
sively licensed from the University of Arkansas.  TiFiber initially focused on photocatalytic membranes for water and air 
filtration where there is great need for filtration improvement, especially in cases where high temperature sterilization is 
required or where biofouling occurs rapidly.  In 2013, the company expanded its intellectual property foundation by licens-
ing an additional technology, a family of synthetic antimicrobial polymers, originally developed at the University of Auckland 
(New Zealand).  Initial applications being developed are for personal care products, wound care dressings, medical devices 
and textiles.  Products are currently in the research and development stage and discussions are underway with large, multi-
national companies for co-development of products.   
     On December 18, 2014, TiFiber, Inc. announced its plans to locate its pilot production facility and future company head-
quarters in Fort Smith, Arkansas to further develop and produce innovative new materials that safely and effectively control 
dangerous microorganisms.  Fort Smith was chosen not only because of its historic, strong support for manufacturing, but 
also due to regional leaders’ efforts to attract leading edge, technology-based companies such as TiFiber. 
     In 2015, pilot-scale production will be established in order to support regulatory certification with the Food and Drug 
Administration (FDA).  Once TiFiber’s products have obtained regulatory approval, a full production facility will be estab-
lished to provide AMP materials to manufacturers for inclusion into their products.  It is anticipated that TiFiber’s Fort 
Smith facility will begin significant production in 2017, and create up to 100 jobs by 2019.   
     Potential applications of TiFiber’s AMP technology include soaps, disposable and non-disposable medical plastics, dental 
cements, wound care (acute and chronic wounds), medical devic-
es (biofilm protection), cosmetic preservatives, and textiles. Ini-
tial development work has been supported by a combination of 
private investment and economic development incentives from 
the State of Arkansas. “TiFiber’s business outlook is very posi-
tive, as the company’s AMP technology meets urgent market 
needs. The company is highly likely to create numerous science 
and engineering jobs in Arkansas,” said Dr. Calvin Goforth, inter-
im CEO of TiFiber. “We are very appreciative of financing and 
tax credits received from the Arkansas Science and Technology 
Authority, the Arkansas Development Finance Authority, and the 
Arkansas Economic Development Commission, that are targeted 
to help create these types of jobs in Arkansas, and which have 
played a critical role in TiFiber’s launch and rapid progress.”  
 
This article is an exerpt from PRWeb.  The entire article can be 
viewed at http://bit.ly/15PiE4t. 
        
On the Go 
     Chen, J.; Site-Selective Seeded 
Growth of Bimetallic Nanostructures 
and their Catalytic Applications, Depart-
ment of Chemistry, Missouri State Uni-
versity, Springfield, MO, January 28, 
2015; Brown University, February 5, 
2015; University of Oklahoma, March6, 
2015. 
Publications 
       G.D. Keeler, J.M. Durdik, J.A. 
Stenken, Localized Delivery of Dexa-
methasone-21-Phosphate via Microdialy-
sis Implants in Rat Induces M(GC) Mac-
rophage Polarization and Alters CCL2 
Concentrations, Acta Biomaterialia, 
2015, 12, 11-20.  DOI: 10.1016/
j.actbio.2014.10.022. 
     J.A. Stenken and A.J. Poschen-
rieder, Bioanalytical Chemistry of Cy-
tokines - A Review, Analytica Chimica 
Acta, 2015, 853, 95-115. doi:10.1016/
j.aca.2014.10.009. 
     Marion G. Götz, Hiroko 
Takeuchi, Matthew J. Goldfogel, Julia 
M. Warren, Brandon D. Fennell and 
Colin D. Heyes.  Visible-Light Pho-
tocatalyzed Cross-Linking of Diacety-
lene Ligands by Quantum Dots to 
Improve Their Aqueous Colloidal Sta-
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bility.  J. Phys. Chem. B, (2014), 118, 
14103-14109. 
     Lisunova, M.; Dunklin, J.R.; Jen-
kins, S.V.; Chen, J.; Roper, K.D.  
The Unusual Visible Photothermal 
Response of Free Standing Multi-
layered Films Based on Plasmonic 
Bimetallic Nanocages, RSC Advances, 
2015, DOI: 10.1039/C5RA00682A. 
     Jenkins, S.V.; Qu, H.; Mudalige, 
T.; Ingle, T.; Wang, R.; Wang, R.; 
Howard, P.C.; Chen, J.; Zhang, Y.  
Rapid Determination of Plasmonic 
Nanoparticle Agglomeration Status 
in Blood, Biomaterials, 2015, accept-
ed. 
Dr. Mike Rutheford, TIFiber’s Chief Scientist, tests the efficacy of 
the company’s novel antimicrobial polymers (AMPs), which have 
proven highly effective against many dangerous microorganisms.  
Mike received his Ph.D. in Chemistry from the University of Arkan-
sas in 2010 under the direction of Professor Xiaogang Peng. 
From the Chair - Wesley Stites 
 
     It has been busy here in Fayetteville.  Many of you are aware that several long time faculty members have or soon will re-
tire.  What you may not realize is how much work it is to hire a new faculty member and that is why January was a pretty ex-
hausting month for the current faculty.  I thought it might be interesting for our alumni and friends to know a bit more about 
how we recruit and hire new faculty members. 
     First, in the summer of 2014 we were asked what our hiring wishes for the coming year were.  We indicated that we ex-
pected two vacancies in August, 2015 and hoped for replacements and new hires to grow the faculty to keep pace with student 
enrollment growth.  Our replacement hires were approved, but we weren’t allowed to expand the faculty beyond the current 
size, at least this year.  Next, the faculty began a discussion about what areas in which to hire.  This is based on many factors 
including teaching needs, areas of research that seem likely to be fundable in the future, anticipated retirements, and available 
space.  Ultimately, we decided to look for new assistant professors in the areas of material chemistry and computational bio-
physics.  As soon as advertisements and our recruiting plan were approved (a fairly slow process in the University bureaucra-
cy), we placed ads and started prodding our contacts to find suitable candidates.   
     Over the next few months, dozens and dozens of applications streamed in, around a hundred for each position, along with 
even larger numbers of recommendation letters.  Even when the areas are narrowly defined as these were, many, many people 
are interested in faculty positions at a major research university.  Two committees were appointed from the faculty and did the 
hard work of reading every cover letter, curriculum vita, research plan, teaching philosophy, and recommendation letter.  They 
found many great candidates.  The hard part was deciding who among this stellar group to actually invite.  After each commit-
tee had narrowed the applicants to a short list, the faculty as a whole reviewed those files and we collectively met, discussed 
and voted on whom to interview.  We invited four candidates for each position to visit us and present their past and proposed 
research. 
     That meant sixteen seminars in just four weeks, hundreds of individual meetings, and lots of discussion.  Again the hard part 
was deciding between fantastic candidates.  We voted and then waited again for approval to extend job offers to wind its way 
through the bureaucratic process.  After months and months of work we hope to soon introduce our newest faculty members.  
Why so much care and thought?  Every new faculty member is literally a multi-million dollar bet.  A bet that the new person 
will excel at teaching and research, funded this year by well over a million dollars in start-up costs and commitments to millions 
more in salary and research space costs.  And unlike a horse race, that bet will take years to see if we were right or wrong.  
Our department has a great track record on placing good bets on new faculty, but with record growth in the student body and 
an increasingly uncertain funding environment for chemical and biochemical research, the stakes have never been higher.  Keep 





     James Beckman graduated in 1965 from U of A with a B.A. in Chemistry. As many of our stu-
dents do, he continued on to medical school at UAMS, then residencies in general surgery and plas-
tic & reconstructive surgery before returning to Fayetteville and plastic surgery practice 1980-2000.  
Now retired from practice, he circled back to chemistry in some ways, as he is still very active as 
director of R & D at Therapon Skin Health, a global skin care products company he founded in 1992.  
     From years of treating severely burned patients, he realized that there was a large need to re-
store mobility, suppleness, and softness to skin grafted hands so that patients could again bend fin-
gers or grasp objects.  No satisfactory skin treatment was available without prescription.  His degree 
in chemistry from the U of A and a passion for knowing the details of skin anatomy, physiology, and 
function led to searching hundreds of articles in the library.  
     This led to lab formulations with clinical testing to find the “ultimate skin restoration cream.” The vision was to create a 
simplified method, a daily skin care system that would restore and rejuvenate aging skin to a beautiful, younger look.  Research 
led to several patents issued or pending. One patent was granted in 2013 for a nanoparticle, based on quantum physics proper-
ties, to “trap” 98% of UVA & UVB energy before it gets to the skin surface.  Another patent pending stimulates apoptosis 
(natural cell death) of malignant skin cancer cells when activated by halogen (visible) light rays. Ninety-eight percent (98%) plus 
of human melanoma cells in living culture were killed in one hour exposure to ordinary halogen light. A third patent, now 
pending, is for a method of reversing burn injury inflammatory events and symptoms. 
     The result was the Theraderm product family that restores sun-damaged or aged skin and produces youthful, natural beau-
ty.  It was a natural progression to start a company, Therapon (www.therapon.com) based here in NWA, to provide these new 
products to other plastic surgeons and dermatologists for their patients. 
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Dr. Xiadong Michael Shi, Associ-
ate Professor at West Virginia Uni-
versity, will present “Catalysis Based 
on 1,2,3 Triazole Ligand: Chemistry Be-
yond ‘Click’” on February 23, at 3:30 
p.m. in CHEM 144.   
Dr. Toru Shiozaki, Assistant Profes-
sor at Northwestern University, will 
present “Active Space Decomposition The-
ory for Excited States and Strongly Corre-
lated Systems” on February 2 at 3:30 p.m. 
in  CHEM 144. 
Dr. Song Jin, Professor, University of Wis-
consin-Madison, will present “Dislocation-
Driven Nanomaterial Growth and Solar Energy 
Conversion using Earth-Abundant Nanomateri-
als” on March 9 at 3:30 p.m. in CHEM 144. 
UA Chemistry Associate Professor Adams Recognized by The Protein Society 
 
The National Organization for the Professional Advancement of Black Chem-
ists and Chemical Engineers, NOBCChE (pronounced no-buh-shay), is an 
organization that promotes careers in chemistry, chemical engineering, and 
related fields as an achievable goal for minority students K-12.  In addition, 
NOBCChE encourages college students to pursue graduate degrees in STEM 
disciplines.  This year’s conference brought together renowned scientists and 
talented young investigators for interactive and informative meetings in New 
Orleans, LA.  The Protein Society received an invitation to attend by Paul D. 
Adams, Ph.D., who was selected as the 2013 NOBCChE President’s Award 
for Excellence in STEM Research and Mentoring.      
                                                                                                                                           Associate Professor Paul Adams                         
The Protein Society Member E-News, December 2014               http://bit.ly/1A2hTm4                                                                                                
Stenken to Help Lead $375,000 Interdisciplinary Project 
 
Professor Julie Stenken and Physics Assistant Professor Woodrow Shew were awarded $375,000 by the National Insti-
tute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to investigate the interplay of two 
types of signaling in the brain.  Under the grant, the investigators will develop new tools which - for the first time - will 
measure changes in the electrical signals due to carefully controlled and measured changes in chemical signals within a 
neuronal circuit.  See the full Newswire article at http://bit.ly/1yUrcm6.   
Dr.  Stephan Link,  Associate 
Professor at Rice University, will 
present “Collective Plasmon Modes 
in Nanoparticle Assemblies” on Feb-
ruary 15 at 3:30 p.m. in CHEM 
144. 
 
Mr. Les Johnson, Senior Technical 
Advisor at RRD International, will 
present a seminar March 30 at 3:30 
p.m. in CHEM 144. 
Dr. Elvin T. Price, Assistant 
Professor, UAMS College of 
Pharmacy, will present a seminar 
March 16 at 3:30 p.m. in CHEM 
144. 
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The Cautionary Tale of Lysostaphin 
 
     Bringing a new drug to market is 
risky business.  Researchers thinking of 
starting their own company should 
enter with eyes-wide open and build a 
solid business team to develop cus-
tomers and human relationships need-
ed for success. Even then, there are no 
guarantees. An example of this is the tale of Lysostaphin. 
A researcher's dream come true 
     Lysostaphin is an antimicrobial agent against Staphylo-
coccus aureus, commonly referred as staph bacteria. A 
company called Biosynexus Incorporated undertook the 
commercialization of Lysostaphin and things started well. 
Drug development was supported by an NIH-COBRE/
BRIN grant and partially funded by Biosynexus themselves. 
In the early 2000's at the University of Arkansas, Dr. Jeff 
Lu (now a senior staff scientist at ArmaGen Technologies) 
solved the molecule structure's targeting domain as part of 
his Ph.D thesis in Dr. Joshua Sakon’s lab (Lu et al. JBC 
2006, 281:549).  
     This industry-university collaboration's success aided 
the development of lysostaphin as a treatment option 
against methicillin resistant S. aureus infection. The drug 
quickly went through Phase I/II trials.  A huge advancement 
in the field at the right time.    
A major equity event, the dream of every 
start-up 
     In late 2002, Biosynexus teamed up with the pharma-
ceutical GlaxoSmithKline (GSK) (see http://bit.ly/18yGec). 
For a start-up bio tech this was a huge coup – investors, a 
major customer paying royalties, and manufacturing re-
sources helped bring this drug to market. Then in 2005, 
Biosynexus was bought by QVT Fund LP (see http://
bit.ly/1yQBdAF). 
Broken dreams 
     I wish I could say that everyone involved stayed on 
cloud 9.  However by 2006, things were unraveling at the 
seams.  Biosynexus took GSK to court (and won) over 
technology being transferred to a GSK sub-contractor/
competitor to Biosynexus.  The case is somewhat compli-
cated and if you’re a biotech CEO or founder, I recom-
mend you read it to learn some industry insider practices 
at http://bit.ly/15YPUHp. 
     Within a year, the QVT buyout went seriously wrong.  
QVT refused to pay the Biosysnexus investors full amount, 
claiming a whole host of faults, such as false representa-
tions of drug effectiveness and breached agreements with 
a third-party license.  And of course, the Biosysnexus in-
vestors counter sued.  (See http://bit.ly/1DcfWRj).  The 
train wreck continued with the Biosysnexus investors later 
suing the legal firm for legal failures in the contract writing
(see http://bit.ly/15YRmt9).  It appears on the surface that 
the Biosysnexus investors won every challenge, but at    
 
 
enormous cost and time.  Again, if you’re a biotech CEO 
or founder, I encourage you to read these sources for 
industry insider practices. 
What happened to Lysostaphin? 
     Well, I’m not completely sure.  It seems that Lyso-
staphin gained a second-life at Bharat Biotech, a company 
in India.  Bharat bought the Lysostaphin patent in 2009 
and their website says it is in Phase II trials (see http://
bit.ly/15YS4a0).   
     It is murky whether Bharat’s product is the same 
product as Biosysnexus because research samples can be 
produced easily and there are many scholar papers.  My 
guess is that Lysostaphin has become the grandmother of 
a host of new drugs in the fight against Staphylococcus. 
Four quick take-aways on Technology Com-
mercialization 
1) Startups are very risky and time consuming.  And 
tough, too!  Sorry to say, but I have met more than 
one academic that have problems accepting this.  
The common statement I hear is: I have a patented 
idea (like Lysostaphin) and people can’t do nothing’ 
without paying me.  Sorry to say, but in reality, pa-
tents can be bypassed and the real value of an idea is 
small until an end customer values it.  This requires a 
product go through applied research, Phase I, II, III 
testing, and reliable manufacturing.  Ask the folks at 
Biosysnexus how difficult things can get. 
2) Startups require a balanced, united, talented team; 
each skilled in their area of expertise.  I ask myself, 
did the root of the legal problems stem from the 
first GSK license not done right?  Did Biosynexus 
have the required level of legal and manufacturing 
expertise?  Getting the right people is a very difficult 
thing to do as a start-up.  Founders try to balance 
the cost between people expertise and winning that 
first big customer needed to keep the company go-
ing.  This is a trade-off that keeps a CEO up at night.  
I suggest starting early to find and build your team. 
3) Quality of a person’s character matters more than 
IQ or money.  More questions:  Why couldn’t QVT 
and Biosynexus work things out?  Did Biosynexus lie 
during the buyout process?  Did QVT try to squeeze 
the smaller start-up?  Both?  All these questions go 
back to the character of the people involved.  It can 
be tough to follow the spirit of the agreement. 
4) Good tech lives on.  Lysostaphin was picked up by 
an ambitious company.  Others see the potential and 
are now carrying the load to provide the final bene-
fits to society. 
5) Good people live on.  Although the original scien-
tists/founders may not get financially rewarded, that 
does not mean that they did not significantly contrib-
ute to helping society.  Their learned skills can carry 
their careers onward. 
 
Written by Scott Weaver, principle consultant at Arise2, www.arise2consult-
ing.com with significant contribution from Dr. Joshua Sakon. 
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Science Building Renamed Discovery Hall 
 
A little confusion now may prevent more confusion later.  That is one 
main reason why the Science Building (four letter building code SCIE) is 
having its name changed to Discovery Hall (DISC).  The Science Building 
has served as the main home for teaching laboratories for both the De-
partment of Chemistry and Biochemistry and the Department of Biologi-
cal Sciences for about forty years.  And, for much of that time students 
have confused the Science Building with the nearby Science Engineering 
Building. 
 
“Homework assignments shoved under teaching lab doors, students wandering into offices in the first few weeks of class 
looking for their lab; it happens every semester,” said Dr. Wesley Stites, chair of the chemistry and biochemistry depart-
ment, “but when emergency services went to the wrong building twice in two weeks early this fall, that was too much.  I 
understand why the ambulance crews got confused, it confuses everyone.  These two calls were for students with long-
term medical conditions. Fortunately, no harm resulted from the delayed response, but I didn’t want to try our luck any 
further after that.”  A suggestion to change the name of the building was quickly approved. 
 
Aside from safety and helping students quickly find the correct building, the name change also points out the investment 
the University of Arkansas is making in teaching labs.  Much of the biological sciences teaching labs will soon move into the 
new Champions Hall on Dickson Street, across from Science Engineering.  Major renovations in the Science Building have 
been ongoing for years, renovations in the newly renamed Discovery Hall will continue, until in a few years when the en-
tire building will effectively be new.  The Department of Chemistry and Biochemistry will expand into space vacated by the 
Department of Biological Sciences, and advanced biological science laboratories will continue to be taught in Discovery 
Hall, but all spaces will be updated to meet current needs and modern laboratory standards.  These departments will be 
joined by the Department of Anthropology, which will move in fall 2015 from their current single, cramped teaching lab in 
Kimpel Hall into three renovated labs in Discovery Hall.   
 
The process of changing the name will take a while to be completed.  Signs outside the building have already been changed, 
but updating maps, information kiosks, and all the documents, and websites that refer to the Science Building will take long-
er.  This will likely cause short-term confusion, but in the long-term the university hopes that Discovery Hall will be a name 
that everyone understands marks its commitment to provide the best possible facilities to its students.  And hopefully, no-
body slides their homework assignment under the wrong door at 2:00 a.m. anymore. 
Dustin Baucom entered the 
program in the fall of 2013.  He 
received his BS from Northeast-
ern State University in 
Tahlequah, OK.  His advisor is 
Colin Heyes. 
Abdullah Qassab entered the 
Cell and Molecular Biology pro-
gram in the spring of 2013.  He 
received his BSc and MSc degrees 
from Salahaddin University in Iraq.  
His advisor is Wesley Stites. 
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Ayinuola Receives Award 
 
     The Younger Chemists Committee (YCC) of the Ameri-
can Chemical Society has recognized 
Kolawole Ayinuola as a recipient of 
a Leadership Development Award to 
support his participation in the YCC 
Leadership Development Workshop.  
The YCC program recognizes emerg-
ing leaders in the profession and helps 
them prepare for the leadership op-
portunities at volunteer organizations, 
such as ACS, and in their professional 
careers.  The workshop was held from Friday, January 23 to 
Sunday, January 25, 2015, in conjunction with the ACS Lead-
ership Institute in Dallas, Texas. During the workshop, partici-
pants engaged in discussions about the characteristics and 
behaviors of effective leaders, identi-
fied leadership skills, developed a 
person leadership development plan, 
and learned about leadership oppor-
tunities within the American Chemi-
cal Society.   
 
7th Grade Science Students Visit the U of A 
 
     On Wednesday, November 19, 7th graders at The New 
School in Fayetteville, AR visited the University of Arkansas 
campus for demonstrations and a tour as part of an ongoing 
collaboration between the Middle School at TNS, the U of A, 
and Missouri University of Science and Technology, to en-
hance the science experience through “viral learning,” partially 
supported by the National Science Foundation (NSF) and the 
American Chemical Society (ACS).  The purpose of this trip 
was to acquaint Ms. Heather Overton’s 7th grade science 
class at TNS with U of A science facilities and with graduate 
and undergraduate students in the research laboratory of Dr. 
Ingrid Fritsch.  The 7th graders learned about probing brain 
chemistry, energy storage and conversion by building potato 
batteries, moving microscopic fluids with magnetism and elec-
tricity, weighing a single molecule, using X-rays and nuclear 
magnetic resonance to determine the structure of molecules, 
and the importance of laboratory safety.  Other participants 
were Willard Keirn and Jade Rundle from TNS, and Drs. Jim 
Hinton, Bill Durham, 
Katarzyna Janowska, and 
students Ben Jones, Mengjia 
Hu, Adam Kreidermacher, 
Foysal Khan, and Corinne 
Songer from the U of A. 
 
Ph.D. graduate student Ben Jones 
(middle) hosts the activity on energy 
(building potato batteries) with TNS 7th 
graders at the University of Arkansas. 
 
 
Impact Ministry with the Morrises 
 
     Jacqueline and 
Scott Morris helped host 
a Christmas party through 
the Impact ministry at 
Cross Church in Spring-
dale. Says Jacqueline, “We 
had over 100 kids, about 
15 parents, and 20 volun-
teers. We taught a lesson 
on the meaning of why we 
celebrate Christmas, Jesus 
Christ's birth. We had 
pizza, desserts, and drinks 
for every person. We did 
crafts inside the town-
house our church owns, games outside for the boys, a 
Girl Scout brought every child a hope box to show them 
that they are loved by God, a goodie bag and stuffed ani-
mal for every kid. With the donated gifts we had a draw-
ing for the 55 presents, 
and a drawing for gift 
cards for adults. Every 
adult actually got a gift 
card to either Subway 
or Chick Fil A. It was 
such a blessing to have 
so many donated gifts 
from David and Vicky 
Hayes, David Paul, 
Pooja Bajwa and 
Marlena Patrick! The 
weather was great too 
so we got to be outside. 
The volunteers were a 
lot of college kids from 
our church who just 
wanted to help out on a Saturday :) such a huge success 





Marcus and Deepika (Talla) 
Henze announce the birth 
of their daughter, Arya 
Henze, September 30, 
2014.  Deepika and family 
live in the San Francisco 
Bay area.  The lure of Bio-
tech industry brought them 
there from Chicago in mid-
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The department of chemistry and biochemistry at the University of Arkansas strives for excellence in research, teaching and 
service in chemistry - the central science.  We aspire to positions of leadership regarding the discovery of new scientific 
knowledge, the training of students, and the economic development of the State of Arkansas.  We seek to recruit and retain a 
diverse group of the best faculty, students and staff to address the challenges of the future through interdisciplinary and multi-
disciplinary research and education. 
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Library Hours 
Excellence in the Central Science 
We’re on the web! 
chemistry.uark.edu 
& 
Department of Chemistry and 
Biochemistry *University of 
Arkansas 
Safety Tip: 
by Bill Durham 
 
Peroxides, azides and 
perchlorates, in general, 
should not be mixed 
with any other waste.  
There are others and 







Calendar of Events 
February 
2 Seminar: Toru Shiozaki, Northwestern University, 
3:30, CHEM 144 
13 CUME - 5:00-6:00, CHEM 144 
14 Valentine’s Day 
16 Seminar: Stephan Link, Rice Univ., 3:30, CHEM 144 
23 Seminar:  Xiaodong Shi, West Virginia University, 
3:30, CHEM 144 
 
March 
1 Application Deadline for students who plan to grad-
uate at the end of Spring 
8 Daylight Saving Time begins.  Spring forward! 
9 Seminar: Song Jin, Univ. of Wisconsin-Madison, 3:30, 
CHEM 144 
13 CUME - 5:00-6:00, CHEM 144 
14 Pi Day - This year is special. Can you guess why? 
16 Seminar: Elvin T. Price, UAMS College of Pharmacy, 
3:30, CHEM 144 
17 St. Patrick’s Day 




CHBC Library (CHEM 225) 
http://libinfo.uark.edu/chemistry 
Spring Semester Hours:  January 11 - May 10 
 
Regular Spring Hours  
Saturday and Sunday  CLOSED 
Monday – Thursday  8:00 am – 9:00 pm 
Friday    8:00 am – 6:00 pm  
Exceptions to Regular Spring Hours  
Friday  Mar 20    8:00 am - 5:00 pm 
M-Th, Mar 23 -26 Spring Break 8:00 am - 5:00 pm 
Friday Mar 27   Closed 
Friday May 8   8:00 am - 5:00 pm 
Intersession Hours: May 11 - 23 
M-F    8:00 am - 5:00 pm 
Saturday and Sunday  CLOSED 
 
The chemistry and biochemistry library resources can be  
accessed in the following LibGuides:  http://uark.libguides.com/
content.php?pid=110953.  Please bookmark for future use. 
Theses and dissertation resources can be found on the following  
LibGuide:  http://uark.libguides.com/content.php?pid=123035 &sid=1057466. 
Save the Date! 
 
The 2015 INBRE conference  
will be held November 6-7 






Department of  Chemistry 
and Biochemistry 
CUME Dates Announced 
 
 








5:00-6:00 p.m., CHEM 144 
NOTICE:  The Mole is moving to a 
bi-monthly format.  Our next publica-
tion will be at the first of April, and 
will cover news that happens during 
February and March.  Please continue 
to submit news articles in a timely 
fashion each month. 
